In the same breath that the Drug Enforcement Administration (DEA) claimed it's moving forward to facilitate and expand scientific and medical research for marijuana in the U.S., the agency said this week that decisions on pending applications from entities seeking to be registered to manufacture marijuana for that research will have to wait until the agency proposes new regulations to govern a growers program.